Let the 450 day CR% numbers talk.If you want to feel good about your investment in TLT, always recheck the 450 CR% numbers.
2Q2020.......90DayCR% = 25%CR.........450DayCR%.......(No data yet).
1Q2021...............".............= 33.3%CR...............".................(No data yet).
3Q2021...............".............= 42%CR..................".................12%CR
April,2022............".............= 44.7%CR..............."................18.4%CR.
Aug,2022.............".............= 50.7%CR..............."................21%CR.
Nov 2022.............".............= 53%CR.................."................28%CR.
1) The FDA know that as more optimized patients are treated the 450day 28%CR will go up.
2) Big Pharma also know that as more optimized patients are treated the 450day 28%CR will go up.
3) We must keep in mind, that every time the 450day CR% goes up, the $value of a big pharma deal goes up.
In short...Big pharma can't afford to wait too long to engage in a money deal talk with TLT.
4) Many doctors refuse to recommend the use of Keytruda for their patients.
5) The FDA has to find an affordable alternative to Keytruda, or many patients will needlessly die because of a lact of better treatments.
6) The time is ripe for the FDA to consider giving TLT treatment a chance with BTD.
Note: I don't worry about the SP or financing, as we all know that it is the 450dayCR% that will determine TLT future, and the 450dayCR% numbers are getting better and better, and nobody on this board can contradic that fact.
From 12%CR to 28%CR at 450day in approximately 12 months(140% increase).
Ask yourself, with more optimized patients treated, what will be the 450dayCR% in 6 or 12 months, and does the FDA already know the answer to that question?
Understanding that the FDA & Big Pharma are aware that the 450dayCR% numbers are increasing steadily, always give me a good and reassuring feeling about my investment in TLT.